Diana Lüftner

Sep 16, 2024 | high5oncology.tv | Michael Untch |Sara M. Tolaney |Diana Lüftner

eBC - 100 seconds Endocrine therapy in triple-positive premenopausal patients Survival benefit reported with Pembro Registry data from France - no break in endocrine therapy in young patients CDK4/6i - 100 Seconds Ribociclib in younger patients Evaluation of the patient collective under 40 years Varia Compliance is everything aBC - 100 Seconds Akt-inhibition works with HR+ but not with mTNBC No benefit of Akt-inhibition in mTNBC TILs and overall suvivial in the shortHER trial aBC - 100...

Jun 3, 2024 | high5oncology.tv | Valentina Guarneri |Diana Lüftner |Alessandra Gennari |Volkmar Müller

Breast cancer early - 100 seconds ENG Breast cancer early - 100 seconds multi language Breast cancer metastatic - 100 seconds ENG Endocrine therapy with Palbociclib + Trastuzumab Chemo-free regimen in HER2+ luminal breast cancer Systemic therapy of HER2+ patients with brain metastases Leptomeningeal metastases in HER2+ mBC Novel ADC-ICI combination therapy HER2+ mBC 1stL T-Dxd Low ER-receptor: endocrine therapy necessary after all? Broaden T-DXD as therapy standard for HER2low and ultra-low...